Bluejay Diagnostics (BJDX) Competitors $1.98 -0.23 (-10.41%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.96 -0.02 (-1.26%) As of 04/17/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. XAIR, QTI, VVOS, LFWD, PETV, IRIX, NMTC, ALUR, NRXS, and ICUShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Beyond Air (XAIR), QT Imaging (QTI), Vivos Therapeutics (VVOS), ReWalk Robotics (LFWD), PetVivo (PETV), IRIDEX (IRIX), NeuroOne Medical Technologies (NMTC), Allurion Technologies (ALUR), NeurAxis (NRXS), and SeaStar Medical (ICU). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Beyond Air QT Imaging Vivos Therapeutics ReWalk Robotics PetVivo IRIDEX NeuroOne Medical Technologies Allurion Technologies NeurAxis SeaStar Medical Bluejay Diagnostics (NASDAQ:BJDX) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, community ranking, institutional ownership, profitability, dividends and analyst recommendations. Is BJDX or XAIR more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to Beyond Air's net margin of -1,730.00%. Bluejay Diagnostics' return on equity of -155.67% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets Bluejay DiagnosticsN/A -155.67% -117.82% Beyond Air -1,730.00%-226.01%-109.75% Which has higher earnings and valuation, BJDX or XAIR? Bluejay Diagnostics has higher earnings, but lower revenue than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBluejay Diagnostics$250K4.39-$9.95M-$772.370.00Beyond Air$3.02M5.45-$60.24M-$1.06-0.23 Do institutionals & insiders have more ownership in BJDX or XAIR? 18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 0.4% of Bluejay Diagnostics shares are held by insiders. Comparatively, 20.1% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to BJDX or XAIR? In the previous week, Bluejay Diagnostics and Bluejay Diagnostics both had 3 articles in the media. Beyond Air's average media sentiment score of 0.17 beat Bluejay Diagnostics' score of -0.03 indicating that Beyond Air is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bluejay Diagnostics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beyond Air 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor BJDX or XAIR? Beyond Air received 46 more outperform votes than Bluejay Diagnostics when rated by MarketBeat users. Likewise, 69.57% of users gave Beyond Air an outperform vote while only 66.67% of users gave Bluejay Diagnostics an outperform vote. CompanyUnderperformOutperformBluejay DiagnosticsOutperform Votes266.67% Underperform Votes133.33% Beyond AirOutperform Votes4869.57% Underperform Votes2130.43% Do analysts recommend BJDX or XAIR? Beyond Air has a consensus target price of $3.67, suggesting a potential upside of 1,430.33%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Bluejay Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bluejay Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Beyond Air 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, BJDX or XAIR? Bluejay Diagnostics has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.15, indicating that its stock price is 85% less volatile than the S&P 500. SummaryBeyond Air beats Bluejay Diagnostics on 13 of the 18 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.10M$4.04B$5.30B$7.35BDividend YieldN/A46.44%5.45%4.30%P/E Ratio0.0027.6821.8617.81Price / Sales4.3947.06380.6697.70Price / CashN/A51.0838.2634.64Price / Book0.005.816.453.98Net Income-$9.95M$67.09M$3.22B$247.81M1 Month Performance-51.71%-11.64%-9.75%-7.92%1 Year Performance-99.10%14.55%11.50%1.52% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.4918 of 5 stars$1.98-10.4%N/A-99.1%$1.10M$250,000.000.009Short Interest ↑XAIRBeyond Air4.2152 of 5 stars$0.24-2.3%$3.67+1,453.0%-79.9%$16.24M$3.02M-0.2270QTIQT ImagingN/A$0.56+1.8%N/A-8.6%$15.20M$4.00M0.00N/APositive NewsGap UpVVOSVivos Therapeutics1.5806 of 5 stars$2.52-1.2%$6.30+150.0%-21.1%$14.84M$14.58M-0.44160Analyst ForecastNews CoverageLFWDReWalk Robotics2.6453 of 5 stars$1.37-6.8%$9.00+556.9%-71.5%$14.56M$25.66M-0.5560Short Interest ↓PETVPetVivoN/A$0.61flatN/A-22.8%$14.51M$1.05M-1.3620IRIXIRIDEX1.3414 of 5 stars$0.85-1.4%$2.00+135.3%-66.2%$14.27M$48.67M-1.27120Analyst ForecastHigh Trading VolumeNMTCNeuroOne Medical Technologies0.2768 of 5 stars$0.43-8.8%N/A-49.1%$13.37M$5.75M-1.6720News CoverageGap UpHigh Trading VolumeALURAllurion Technologies2.1635 of 5 stars$2.74-5.5%$22.83+733.3%-95.3%$13.14M$32.11M-0.23501Short Interest ↑Gap UpNRXSNeurAxisN/A$1.75-5.7%N/A-49.4%$12.59M$2.69M-0.9519Gap UpICUSeaStar Medical0.0838 of 5 stars$1.34-3.6%N/A-90.7%$11.69M$135,000.00-0.122Short Interest ↑Negative News Related Companies and Tools Related Companies Beyond Air Alternatives QT Imaging Alternatives Vivos Therapeutics Alternatives ReWalk Robotics Alternatives PetVivo Alternatives IRIDEX Alternatives NeuroOne Medical Technologies Alternatives Allurion Technologies Alternatives NeurAxis Alternatives SeaStar Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BJDX Stock Free BJDX Stock Alerts